SY
Sameer Yusuf Khan
About Sameer Yusuf Khan
Data last updated:
Sameer Yusuf Khan was a Director at Sarvhit Bhavishya Nidhi Limited (2015–2016), Company Secretary at Renovision Exports Private Limited (2018–2020) and Director at Zira Poorvanchal Pharmaceuticals Limited (from 2014), and held 5 more directorships. The companies operate in Financial Services and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Feb 2015 | 2015 | Active | ||
| Company Secretary | 30 Jun 2018 | 1994 | ₹31.25 Cr (FY 2025) | Active | |
| Director | 12 Nov 2014 | 2014 | Strike Off | ||
| Director | 24 Mar 2014 | 2014 | Strike Off | ||
| Director | 10 Oct 2012 | 2012 | Strike Off | ||
| Director | 16 Dec 2013 | 2013 | Strike Off | ||
| Director | 24 Mar 2014 | 2014 | Strike Off | ||
| Director | 19 Mar 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sameer Yusuf Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sameer Yusuf Khan
Sameer Yusuf Khan was first appointed on 10 Oct 2012 as Director at Poorvanchal Victual Products Limited. The most recent appointment on record is 30 Jun 2018 at Renovision Exports Private Limited.
Sameer Yusuf Khan held 8 earlier board appointments: Sarvhit Bhavishya Nidhi Limited (Director, 16 Feb 2015 to 06 Apr 2016); Renovision Exports Private Limited (Company Secretary, 30 Jun 2018 to 05 May 2020); Zira Poorvanchal Pharmaceuticals Limited (Director, from 12 Nov 2014); Poorvanchal Schools Supplement And Publishing Limited (Director, from 24 Mar 2014); Poorvanchal Victual Products Limited (Director, from 10 Oct 2012); and 3 more.